[1]
“Development and Evaluation of a Chitosan-based Topical Gel of Dinalbuphine sebacate for Targeted Management of Rheumatoid Arthritis”, AJP, vol. 19, no. 2, Jul. 2025, doi: 10.22377/ajp.v19i2.6471.